FOLH1 and posterior cortical atrophy: More recently, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging performed with both PET/MRI or PET/CT tomographs has emerged as a promising and useful modality for both staging and restaging settings of PCa patients, as well as for the assessment of therapeutic response and therefore of prognosis prediction [8,9,10,11].